Inducing ocular allergy with beta-lactoglobulin: a new experimental model

Area of Science:

• Ophthalmology
• Immunology
• Allergology

Background:

• Ocular allergies affect millions globally, necessitating robust animal models for research.
• Existing models may not fully capture the complex immune responses involved in allergic conjunctivitis.

Purpose of the Study:

• To establish a novel murine model for acute allergic conjunctivitis.
• To induce allergic reactions using beta-lactoglobulin (BLG), a common cow's milk allergen.
• To characterize the clinical, histopathological, and immunohistochemical features of the induced model.

Main Methods:

• Balb/c mice were divided into groups and immunized with varying concentrations of topical BLG (2.5, 5, or 10 mg/ml) and systemic immunization.
• A control group received aluminum hydroxide (alum) alone.
• Animals were assessed clinically, histopathologically (mast cell and eosinophil infiltration), and immunochemically for T helper type 1 (Th1) and T helper type 2 (Th2) cytokines.

Main Results:

• All study groups demonstrated induced allergic conjunctivitis, with 5 mg/ml topical BLG identified as an optimized dosage.
• The induced conjunctivitis exhibited both Th1 and Th2 immune responses, with a slight predominance of the Th1 reaction.
• Clinical and immunohistochemical findings confirmed successful model development.

Conclusions:

• A new murine model for acute allergic conjunctivitis induced by BLG has been successfully developed.
• This model exhibits immune parameters consistent with the late phase of acute allergic conjunctivitis.
• The model offers a valuable alternative for studying ocular allergy pathogenesis and evaluating potential treatments.